Miracor Medical
Medical device company developing an interventional trans-coronary sinus therapy that uses a balloon catheter and a pressure‑controlled console to improve microvascular perfusion during percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI). The company sponsors multicenter clinical studies, holds CE-mark clearance for specified STEMI indications, and has pursued regulatory approvals including a U.S. FDA investigational device exemption for pivotal clinical evaluation.
Industries
Nr. of Employees
small (1-50)
Miracor Medical
Awans, Walloon Region, Belgium
Products
Pressure-controlled intermittent coronary sinus occlusion therapy system (balloon catheter and control console)
Integrated therapy system comprising a coronary sinus occlusion balloon delivered via venous catheter and a pressure-monitoring console that regulates intermittent inflation/deflation to modify microvascular perfusion during PCI.
PiCSO
Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) is a novel first-line therapy used during PCI to positively change the course for Acute MI patients by reducing infarct size.
PiCSO Impulse System
The PiCSO Impulse System is a coronary sinus intervention system that features balloon inflation which redistributes blood to ischemic areas.
Pressure-controlled intermittent coronary sinus occlusion therapy system (balloon catheter and control console)
Integrated therapy system comprising a coronary sinus occlusion balloon delivered via venous catheter and a pressure-monitoring console that regulates intermittent inflation/deflation to modify microvascular perfusion during PCI.
PiCSO
Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) is a novel first-line therapy used during PCI to positively change the course for Acute MI patients by reducing infarct size.
PiCSO Impulse System
The PiCSO Impulse System is a coronary sinus intervention system that features balloon inflation which redistributes blood to ischemic areas.
Services
Sponsorship and operational execution of multicenter randomized and feasibility clinical studies evaluating adjunctive coronary sinus occlusion therapy in STEMI patients, collecting imaging and physiologic endpoints.
Sponsorship and operational execution of multicenter randomized and feasibility clinical studies evaluating adjunctive coronary sinus occlusion therapy in STEMI patients, collecting imaging and physiologic endpoints.
Expertise Areas
- Interventional cardiology device therapies for STEMI
- Clinical trial design and management for cardiovascular devices
- Coronary microcirculation physiology and measurements
- Adjunctive procedural integration with PCI
Key Technologies
- Pressure-controlled intermittent coronary sinus occlusion
- Real-time pressure-driven device control algorithms
- Invasive microcirculation measurement (IMR, thermodilution)
- Cardiac magnetic resonance imaging for infarct quantification
News & Updates
Agreements signed with regional distributors to support commercial introduction, physician training and market access activities in Italy.
Company-sponsored symposium for discussion of acute myocardial infarction outcomes and learnings with external investigators.
Clinical study reporting infarct size outcomes following pressure-controlled intermittent coronary sinus occlusion during anterior STEMI.
Study showing IMR-guided therapy with intermittent coronary sinus occlusion improved microvascular function and reduced infarct size in STEMI patients.
Safety and feasibility results for pressure-controlled intermittent coronary sinus occlusion in acute STEMI patients.
First-in-man study reporting intracoronary hemodynamic observations during pressure-controlled intermittent coronary sinus occlusion.
Agreements signed with regional distributors to support commercial introduction, physician training and market access activities in Italy.
Company-sponsored symposium for discussion of acute myocardial infarction outcomes and learnings with external investigators.
Clinical study reporting infarct size outcomes following pressure-controlled intermittent coronary sinus occlusion during anterior STEMI.
Study showing IMR-guided therapy with intermittent coronary sinus occlusion improved microvascular function and reduced infarct size in STEMI patients.
Safety and feasibility results for pressure-controlled intermittent coronary sinus occlusion in acute STEMI patients.
First-in-man study reporting intracoronary hemodynamic observations during pressure-controlled intermittent coronary sinus occlusion.